Ping Chen

Shenyang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Profiles of Cough and Associated Risk Factors in Nonhospitalized Individuals With SARS-CoV-2 Omicron Variant Infection: Cross-Sectional Online Survey in China.

Profiles of Cough and Associated Risk Factors in Nonhospitalized Individuals With SARS-CoV-2 Omicron Variant Infection: Cross-Sectional Online Survey in China.

Journal: JMIR public health and surveillance

Published: March 21, 2023

Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies.

Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies.

Journal: Chinese medical journal

Published: February 08, 2023

Associations between comorbidities and annual incidence plus frequency of asthma exacerbation hospitalisation during the past year: data from CARN study.

Associations between comorbidities and annual incidence plus frequency of asthma exacerbation hospitalisation during the past year: data from CARN study.

Journal: BMC pulmonary medicine

Published: January 30, 2022

The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice.

The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice.

Journal: International journal of chronic obstructive pulmonary disease

Published: September 03, 2021

Asthma Management Using the Mobile Asthma Evaluation and Management System in China.

Asthma Management Using the Mobile Asthma Evaluation and Management System in China.

Journal: Allergy, asthma & immunology research

Published: April 14, 2021

Response of patients with chest tightness variant asthma with routine asthma treatment regimen: A 1-year multicenter, prospective, real-world study.

Response of patients with chest tightness variant asthma with routine asthma treatment regimen: A 1-year multicenter, prospective, real-world study.

Journal: Clinical and translational medicine

Published: August 03, 2020

Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians.

Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians.

Journal: Asian Pacific journal of allergy and immunology

Published: April 06, 2020

Chinese expert consensus-based guideline on assessment and management of asthma exacerbation.

Chinese expert consensus-based guideline on assessment and management of asthma exacerbation.

Journal: Journal of thoracic disease

Published: February 08, 2020

Chinese expert consensus on diagnosis and management of severe asthma.

Chinese expert consensus on diagnosis and management of severe asthma.

Journal: Journal of thoracic disease

Published: February 13, 2019

Subgroup Analysis for Chinese Patients Included in the INPULSIS® Trials on Nintedanib in Idiopathic Pulmonary Fibrosis.

Subgroup Analysis for Chinese Patients Included in the INPULSIS® Trials on Nintedanib in Idiopathic Pulmonary Fibrosis.

Journal: Advances in therapy

Published: November 06, 2018

Chronic bronchitis is associated with severe exacerbation and prolonged recovery period in Chinese patients with COPD: a multicenter cross-sectional study.

Chronic bronchitis is associated with severe exacerbation and prolonged recovery period in Chinese patients with COPD: a multicenter cross-sectional study.

Journal: Journal of thoracic disease

Published: January 10, 2018

Prevalence and risk factors of asthma in mainland China: The CARE study.

Prevalence and risk factors of asthma in mainland China: The CARE study.

Journal: Respiratory medicine

Published: January 03, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026